UK markets closed

CollPlant Biotechnologies Ltd. (CLGN)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
5.98-0.12 (-1.97%)
As of 12:15PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
10,959
10,959
299
15,641
6,137
-
Cost of revenue
1,991
1,991
400
2,005
3,002
-
Gross profit
8,968
8,968
-101
13,636
3,135
-
Operating expenses
Research development
10,484
10,484
10,255
7,631
4,065
-
Selling general and administrative
5,996
5,996
6,741
5,940
4,669
-
Total operating expenses
16,480
16,480
16,996
13,571
8,734
-
Operating income or loss
-7,512
-7,512
-17,097
65
-5,599
-
Interest expense
-
-
-
-
-
63
Total other income/expenses net
-285
-285
-115
-10
-141
-
Income before tax
-7,019
-7,019
-16,925
237
-5,774
-
Income from continuing operations
-7,019
-7,019
-16,925
237
-5,774
-
Net income
-7,019
-7,019
-16,925
237
-5,774
-
Net income available to common shareholders
-7,019
-7,019
-16,925
237
-5,774
-
Basic EPS
-0.59
-0.62
-1.53
0.02
-0.84
-
Diluted EPS
-0.59
-0.62
-1.53
0.02
-0.84
-
Basic average shares
11,319
11,389
11,033
9,969
6,887
-
Diluted average shares
11,319
11,389
11,033
11,967
6,887
-